This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wallin, A. Articles by Blennow, K. Search for Related Content PubMed Articles by Wallin, A. Articles by Blennow, K. Social Bookmarking                         What's this?

Heterogeneity of Vascular Dementia: Mechanisms and Subgroups

Department of Psychiatry and Neurochemistry, University of Göteborg, St Jörgen Hospital, Hisings Backa, Sweden.

Kaj Blennow, MD, PhD

Department of Psychiatry and Neurochemistry, University of Göteborg, St Jörgen Hospital, Hisings Backa, Sweden.

Today, multiple, thromboembolically generated cerebral infarcts are regarded as the main pathogenetic pathway of vascular dementia (VAD), with multi-infarct dementia (MID) as its clinical counterpart. However, taking into account other vascular mechanisms that may influence the brain, such as vessel-wall damage (atherosclerosis, hyalinosis, amyloid angiopathy, or blood-brain barrier dysfunction), cerebrovascular insufficiency (disturbance of systemic circulation, perfusion vulnerability related to the vascular anatomy of the brain, or disturbance of autoregulation), and hyperviscosity, it is evident that MID is not the only VAD category. The diagnosis of MID ought to be reserved for the combination of progressive dementia associated with cerebral ischemic events and evidence of infarction that is mainly associated with the large cerebral arteries. Subcortical white-matter dementia characterized by frontosubcortical symptomatology, white-matter lesions, and small-vessel involvement with or without lacunes/infarcts—a combination of lacunar dementia and Binswanger's disease—appears to be another important VAD disease.

Journal of Geriatric Psychiatry and Neurology, Vol. 6, No. 3, 177-188 (1993)
DOI: 10.1177/089198879300600307


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I. Skoog, C. Hesse, P. Fredman, L.-A. Andreasson, B. Palmertz, and K. Blennow Apolipoprotein E in Cerebrospinal Fluid in 85-Year-Old Subjects: Relation to Dementia, Apolipoprotein E Polymorphism, Cerebral Atrophy, and White Matter Lesions Arch Neurol, March 1, 1997; 54(3): 267 - 272. [Abstract] [PDF]